Guardian's clearest advantage is pricing at lower coverage amounts. It’s also one of the few carriers in our analysis that underwrites both term and whole life coverage for healthy, qualified HIV-positive applicants. Most insurers route this population toward guaranteed-issue policies with much lower coverage caps.
Because Guardian is a mutual company, its policyholders share in its profits instead of outside shareholders. Guardian has paid a dividend to eligible whole life policyholders every year since 1868. Dividends aren't guaranteed, but that track record reflects long-term financial consistency.





